Your browser doesn't support javascript.
loading
Turkish Chronic Myeloid Leukemia Study: Retrospective Sectional Analysis of CML Patients.
Sahin, Fahri; Saydam, Güray; Cömert, Melda; Uz, Burak; Yavuz, Akif Selim; Turan, Esra; Yönal, Ipek; Atay, Hilmi; Keltikli, Engin; Turgut, Mehmet; Pehlivan, Mustafa; Akay, Meltem Olga; Gürkan, Emel; Paydas, Semra; Kahraman, Selda; Demirkan, Fatih; Kirkizlar, Onur; Akpinar, Seval; Pamuk, Gülsüm Emel; Demir, Muzaffer; Ozbas, Hasan Mücahit; Sönmez, Mehmet; Gültürk, Mine; Salihoglu, Ayse; Eskazan, Ahmet Emre; Ar, Cem; Haydaroglu Sahin, Handan; Ongören, Seniz; Baslar, Zafer; Aydin, Yildiz; Yenere, Mustafa Nuri; Tüzüner, Nükhet; Ferhanoglu, Burhan; Haznedaroglu, Ibrahim C; Ilhan, Osman; Soysal, Teoman.
Afiliação
  • Sahin F; Ege University Faculty of Medicine, Department of Hematology, Izmir, Turkey.
  • Saydam G; Ege University Faculty of Medicine, Department of Hematology, Izmir, Turkey.
  • Cömert M; Ege University Faculty of Medicine, Department of Hematology, Izmir, Turkey.
  • Uz B; Hacettepe University Faculty of Medicine, Department of Hematology, Ankara, Turkey.
  • Yavuz AS; Istanbul University Faculty of Medicine, Department of Hematology, Istanbul, Turkey.
  • Turan E; Istanbul University Faculty of Medicine, Department of Hematology, Istanbul, Turkey.
  • Yönal I; Istanbul University Faculty of Medicine, Department of Hematology, Istanbul, Turkey.
  • Atay H; Ondokuz Mayis University Faculty of Medicine, Department of Hematology, Samsun, Turkey.
  • Keltikli E; Ondokuz Mayis University Faculty of Medicine, Department of Hematology, Samsun, Turkey.
  • Turgut M; Ondokuz Mayis University Faculty of Medicine, Department of Hematology, Samsun, Turkey.
  • Pehlivan M; Gaziantep University Faculty of Medicine, Department of Hematology, Gaziantep, Turkey.
  • Akay MO; Osmangazi University Faculty of Medicine, Department of Hematology, Eskisehir, Turkey.
  • Gürkan E; Çukurova University Faculty of Medicine Department of Hematology and Oncology, Adana, Turkey.
  • Paydas S; Çukurova University Faculty of Medicine Department of Hematology and Oncology, Adana, Turkey.
  • Kahraman S; Dokuz Eylül University Faculty of Medicine, Department of Hematology, Izmir, Turkey.
  • Demirkan F; Dokuz Eylül University Faculty of Medicine, Department of Hematology, Izmir, Turkey.
  • Kirkizlar O; Trakya University Faculty of Medicine, Department of Hematology, Edirne, Turkey.
  • Akpinar S; Trakya University Faculty of Medicine, Department of Hematology, Edirne, Turkey.
  • Pamuk GE; Trakya University Faculty of Medicine, Department of Hematology, Edirne, Turkey.
  • Demir M; Trakya University Faculty of Medicine, Department of Hematology, Edirne, Turkey.
  • Ozbas HM; Karadeniz Technical University Faculty of Medicine, Department of Hematology, Trabzon, Turkey.
  • Sönmez M; Karadeniz Technical University Faculty of Medicine, Department of Hematology, Trabzon, Turkey.
  • Gültürk M; Istanbul University Cerrahpasa Faculty of Medicine, Department of Hematology, Istanbul, Turkey.
  • Salihoglu A; Istanbul University Cerrahpasa Faculty of Medicine, Department of Hematology, Istanbul, Turkey.
  • Eskazan AE; Istanbul University Cerrahpasa Faculty of Medicine, Department of Hematology, Istanbul, Turkey.
  • Ar C; Istanbul University Cerrahpasa Faculty of Medicine, Department of Hematology, Istanbul, Turkey.
  • Haydaroglu Sahin H; Gaziantep University Faculty of Medicine, Department of Hematology, Gaziantep, Turkey.
  • Ongören S; Istanbul University Cerrahpasa Faculty of Medicine, Department of Hematology, Istanbul, Turkey.
  • Baslar Z; Istanbul University Cerrahpasa Faculty of Medicine, Department of Hematology, Istanbul, Turkey.
  • Aydin Y; Istanbul University Cerrahpasa Faculty of Medicine, Department of Hematology, Istanbul, Turkey.
  • Yenere MN; Ankara University Faculty of Medicine, Department of Hematology, Ankara, Turkey.
  • Tüzüner N; Istanbul University Cerrahpasa Faculty of Medicine, Department of Hematology, Istanbul, Turkey.
  • Ferhanoglu B; Istanbul University Cerrahpasa Faculty of Medicine, Department of Hematology, Istanbul, Turkey.
  • Haznedaroglu IC; Hacettepe University Faculty of Medicine, Department of Hematology, Ankara, Turkey.
  • Ilhan O; Ankara University Faculty of Medicine, Department of Hematology, Ankara, Turkey.
  • Soysal T; Istanbul University Cerrahpasa Faculty of Medicine, Department of Hematology, Istanbul, Turkey.
Turk J Haematol ; 30(4): 351-8, 2013 Dec.
Article em En | MEDLINE | ID: mdl-24385824
ABSTRACT

OBJECTIVE:

here have been tremendous changes in treatment and follow-up of patients with chronic myeloid leukemia (CML) in the last decade. Especially, regular publication and updating of NCCN and ELN guidelines have provided enermous rationale and base for close monitorization of patients with CML. But, it is stil needed to have registry results retrospectively to evaluate daily CML practices. MATERIALS AND

METHODS:

In this article, we have evaluated 1133 patients' results with CML in terms of demographical features, disease status, response, resistance and use of second-generation TKIs.

RESULTS:

The response rate has been found relatively high in comparison with previously published articles, and we detected that there was a lack of appropriate and adequate molecular response assessment.

CONCLUSION:

We concluded that we need to improve registry systems and increase the availability of molecular response assessment to provide high-quality patient care. CONFLICT OF INTEREST None declared.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Turk J Haematol Ano de publicação: 2013 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Turk J Haematol Ano de publicação: 2013 Tipo de documento: Article